Avanos Medical's three largest insider shareholders as of July 26, 2026 are Joseph Fralin Woody (Chief Executive Officer, 402.78K shares), David Pacitti (Chief Executive Officer, 322.19K shares), Scott Michael Galovan (Svp, Chief Financial Officer, 135.60K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Julie Ann Shimer | - | 62,093 | 0 | 06 Jan, 2025 |
| Indrani Lall Franchini | - | 16,820 | 0 | 06 Jan, 2025 |
| Joseph Fralin Woody | Chief Executive Officer | 402,776 | 0 | 10 Mar, 2025 |
| David Pacitti | Chief Executive Officer | 322,194 | 0 | 16 Apr, 2026 |
| Arjun Ranjan Sarker | Senior Vp, International | 26,761 | 0 | 23 Mar, 2023 |
| David Edward Ball | Svp Global Supply Chain | 10,636 | 0 | 08 Sep, 2022 |
| William David Haydon | Svp, Gm Pain Franchise | 28,443 | 0 | 07 Mar, 2023 |
| Kerr Holbrook | Svp, Chief Commercial Officer | 83,860 | 0 | 19 Nov, 2025 |
| Mojirade James | Svp, General Counsel | 104,518 | 0 | 24 Apr, 2025 |
| Lisa Egbuonu-Davis | - | 25,814 | 0 | 06 Jan, 2025 |
| John Joseph Hurley | Principal Accounting Officer | 13,592 | 0 | 17 Mar, 2026 |
| Sudhakar Varshney | Svp, Global Supply Chain | 30,197 | 0 | 07 Mar, 2024 |
| Sigfrido Delgado | Svp, Operations | 55,741 | 0 | 24 Apr, 2026 |
| Scott Michael Galovan | Svp, Chief Financial Officer | 135,596 | 0 | 24 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 22 Apr, 2026 | Sigfrido Delgado | Common Stock | D | 4,264 | $24.64 | 55,741 | D | F |
| 22 Apr, 2026 | Sigfrido Delgado | Common Stock | D | 4,264 | $24.64 | 55,741 | D | F |
| 22 Apr, 2026 | Sigfrido Delgado | Common Stock | D | 4,264 | $24.64 | 55,741 | D | F |
| 22 Apr, 2026 | Scott Michael Galovan | Common Stock | D | 4,228 | $24.64 | 135,596 | D | F |
| 14 Apr, 2026 | David Pacitti | Common Stock | D | 21,194 | $14.53 | 322,194 | D | F |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Common Stock | A | 15,886 | $0.00 | 60,005 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Employee Stock Option (right to buy) | A | 37,520 | $0.00 | 59,434 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Employee Stock Option (right to buy) | A | 37,520 | $0.00 | 59,434 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Employee Stock Option (right to buy) | A | 37,782 | $0.00 | 59,696 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Employee Stock Option (right to buy) | A | 37,520 | $0.00 | 59,434 | D | A |
| 13 Mar, 2026 | Sigfrido Delgado | Employee Stock Option (right to buy) | A | 37,782 | $0.00 | 59,696 | D | A |